beta-Galactosidase-1/GLB1 Antibody (OTI1C9) | Novus Biologicals NBP2-45731 product information

product summary

company name :

Novus Biologicals

other brands :

IMGENEX

product type :

antibody

product name :

beta-Galactosidase-1/GLB1 Antibody (OTI1C9)

catalog :

NBP2-45731

quantity :

0.1 ml

price :

479 USD

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

OTI1C9

reactivity :

human, mouse, dogs

application :

western blot, immunohistochemistry, immunocytochemistry, immunohistochemistry - paraffin section

more info or order :

Novus Biologicals product webpage

citations: 7

Reference
Limberger T, Schlederer M, Trachtov xe1 K, Garces de Los Fayos Alonso I, Yang J, H xf6 gler S, et al. KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis. Mol Cancer. 2022;21:89 pubmed publisher
Lee T, Wu J, Jean W, Condello G, Alkhatib A, Hsieh C, et al. Reduced stem cell aging in exercised human skeletal muscle is enhanced by ginsenoside Rg1. Aging (Albany NY). 2021;13:16567-16576 pubmed publisher
Wu J, Cheng I, Saovieng S, Jean W, Kao C, Liu Y, et al. Aerobic exercise induces tumor suppressor p16INK4a expression of endothelial progenitor cells in human skeletal muscle. Aging (Albany NY). 2020;12:20226-20234 pubmed publisher
Luu A, Wong C, Agrawal V, Wise N, Handyside B, Lo M, et al. Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency. J Biol Chem. 2020;295:13556-13569 pubmed publisher
Wu J, Saovieng S, Cheng I, Liu T, Hong S, Lin C, et al. Ginsenoside Rg1 supplementation clears senescence-associated β-galactosidase in exercising human skeletal muscle. J Ginseng Res. 2019;43:580-588 pubmed publisher
Ma A, Motyka B, Gutfreund K, Shi Y, George R. A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B. Hum Vaccin Immunother. 2020;16:756-778 pubmed publisher
Chen J, Luu A, Wise N, Angelis R, Agrawal V, Mangini L, et al. Intracerebroventricular enzyme replacement therapy with Beta-Galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice. J Biol Chem. 2019;: pubmed publisher

product information

master code :

NBP2-45731

SKU :

NBP2-45731

product name :

beta-Galactosidase-1/GLB1 Antibody (OTI1C9)

unit size :

0.1 ml

description :

The beta-Galactosidase-1/GLB1 Antibody (OTI1C9) from Novus is a mouse monoclonal antibody to beta-Galactosidase-1/GLB1. This antibody reacts with canine,human,monkey,mouse,non-species specific. The beta-Galactosidase-1/GLB1 Antibody (OTI1C9) has been validated for the following applications: IF/IHC,Western Blot,Immunohistochemistry-Paraffin,Immunocytochemistry/ Immunofluorescence,Immunohistochemistry.

target :

beta-Galactosidase-1/GLB1

category :

Primary Antibodies

buffer :

PBS (pH 7.3), 1% BSA, 50% Glycerol

clonality :

Monoclonal

clone :

OTI1C9

concentration :

1 mg/ml

conjugate :

Unconjugated

host :

Mouse

immunogen :

Full length human recombinant protein of human GLB1(NP_001073279) produced in HEK293T cell.

isotype :

IgG2a

purity :

Immunogen affinity purified

species :

Canine,Human,Monkey,Mouse,Non-species specific

theoretical molecular weight :

72.6 kDa

gene symbol :

GLB1

applications :

IF/IHC,Western Blot,Immunohistochemistry-Paraffin,Immunocytochemistry/ Immunofluorescence,Immunohistochemistry

USD :

479 USD

alt names :

Acid beta-galactosidase, beta-galactosidase, EBP, EC 3.2.1.23, Elastin receptor 1, elastin receptor 1 (67kD), elastin receptor 1, 67kDa, ELNR1, galactosidase, beta 1, Lactase, MPS4B

storage :

Store at -20C. Avoid freeze-thaw cycles.

more info or order :

Novus Biologicals product webpage